Inogen, Inc. (INGN)
| Market Cap | 127.96M |
| Revenue (ttm) | 327.86M |
| Net Income (ttm) | -132.50M |
| Shares Out | 23.31M |
| EPS (ttm) | -5.75 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 209,148 |
| Open | 5.63 |
| Previous Close | 5.65 |
| Day's Range | 5.46 - 5.65 |
| 52-Week Range | 4.13 - 26.11 |
| Beta | 1.10 |
| Analysts | Hold |
| Price Target | 7.50 (+36.61%) |
| Earnings Date | Feb 22, 2024 |
About INGN
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrat... [Read more]
Financial Performance
In 2022, Inogen's revenue was $377.24 million, an increase of 5.37% compared to the previous year's $358.00 million. Losses were -$83.77 million, 1222.8% more than in 2021.
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for INGN stock is "Hold." The 12-month stock price forecast is $7.5, which is an increase of 36.61% from the latest price.
News
Inogen to Present at Upcoming Investor Conferences in November 2023
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management wil...
Inogen Announces Third Quarter 2023 Financial Results
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results f...
Inogen to Report Third Quarter 2023 Financial Results on November 7, 2023
GOLETA, Calif.--(BUSINESS WIRE)--Inogen to Report Third Quarter 2023 Financial Results on November 7, 2023.
Inogen Completes Acquisition of Physio-Assist
GOLETA, Calif.--(BUSINESS WIRE)--Inogen Completes Acquisition of Physio-Assist.
Inogen Announces CFO Transition Plan
GOLETA, Calif.--(BUSINESS WIRE)--Inogen Announces CFO Transition Plan. Names Mike Sergesketter as Interim Chief Financial Officer. Reaffirms 2023 Financial Guidance.
Inogen Recognized as a Finalist for Ragan's CSR & Diversity Awards Program
GOLETA, Calif.--(BUSINESS WIRE)--Inogen Recognized as a Finalist for Ragan's CSR & Diversity Awards Program.
Inogen Announces Second Quarter 2023 Financial Results
GOLETA, Calif.--(BUSINESS WIRE)--Inogen Announces Second Quarter 2023 Financial Results.
Inogen Achieves Best In Class 8-Year Expected Service Life Portable Oxygen Concentrators
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the introduction of...
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This MonthSilk Road Me
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Inogen Expands Its Respiratory Product Portfolio with Acquisition of Physio-Assist
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the company ha...
Inogen to Present at 43rd Annual William Blair Growth Stock Conference
GOLETA, Calif.--(BUSINESS WIRE)--Inogen to Present at 43rd Annual William Blair Growth Stock Conference.
Inogen Announces First Quarter 2023 Financial Results
GOLETA, Calif.--(BUSINESS WIRE)--Inogen Announces First Quarter 2023 Financial Results.
Inogen to Report First Quarter 2023 Financial Results on May 4, 2023
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report...
Inogen to Present at 22nd Annual Needham Virtual Healthcare Conference
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management wil...
Inogen Announces Appointment of Tom West to Board of Directors and Retirement of Board Member Kristen Miranda
GOLETA, Calif.
Inogen to Present at KeyBanc Life Sciences & MedTech Investor Forum
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management wil...
Inogen to Provide Strategy Update on February 27, 2023
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will host a...
Inogen Announces Fourth Quarter and Full Year 2022 Financial Results
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results f...
Inogen Achieves Regulatory Milestones to Support Current and Future Products
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has achie...
Inogen Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Within Company Expectations
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced unaudited prelimi...
Inogen to Present at 41st Annual J.P. Morgan Healthcare Conference
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the company ...
Inogen to Present at Upcoming Investor Conferences in November 2022
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following invest...
Inogen Announces Third Quarter 2022 Financial Results
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended September 30...
Inogen to Announce Third Quarter 2022 Financial Results on November 2, 2022
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will issue third ...
Inogen Announces Second Quarter 2022 Financial Results
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results f...